6 d. ago ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7

ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7  Zacks Investment Research

Other

9 d. ago Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer

Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer  StocksToTrade

Other

1 week ago Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer

Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer  StocksToTrade

Other

1 week ago Zimmer Biomet’s iTaperloc Complete and iG7 Hip System approved in Japan

Zimmer Biomet’s iTaperloc Complete and iG7 Hip System approved in Japan  Medical Device Network

Other

1 week ago Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine

Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System  PR Newswire

Other

2 w. ago Verrica to receive $10M payment as Ycanth gains approval in Japan

Verrica to receive $10M payment as Ycanth gains approval in Japan  The Business Journals

Other

2 w. ago Nuvation Bio stock gains as Japan approves IBTROZI for lung cancer

Nuvation Bio stock gains as Japan approves IBTROZI for lung cancer  Investing.com

Other

2 w. ago ARS Pharmaceuticals’ neffy nasal spray gets approval for anaphylaxis in Japan

ARS Pharmaceuticals’ neffy nasal spray gets approval for anaphylaxis in Japan  Medical Device Network

Other

2 w. ago JMP reiterates Market Outperform rating on Esperion stock following Japan approval

JMP reiterates Market Outperform rating on Esperion stock following Japan approval  Investing.com

Other

2 w. ago Astellas’ Izervay gains conditional approval in Japan for GA treatment

Astellas’ Izervay gains conditional approval in Japan for GA treatment  Pharmaceutical Technology

Other

2 w. ago Astellas Pharma Secures Conditional Approval in Japan for Izervay to Treat Geographic Atrophy

Astellas Pharma Secures Conditional Approval in Japan for Izervay to Treat Geographic Atrophy  geneonline.com

Other

2 w. ago Celltrion’s Autoimmune Disease Treatment Aptozma Receives Product Approval in Japan

Celltrion’s Autoimmune Disease Treatment Aptozma Receives Product Approval in Japan  Businesskorea

Other

2 w. ago NovoCure (NVCR): Assessing Valuation After Japan Approves Optune Lua for Advanced Lung Cancer Therapy

NovoCure (NVCR): Assessing Valuation After Japan Approves Optune Lua for Advanced Lung Cancer Therapy  simplywall.st

Other

2 w. ago Esperion stock rises after Japan approves cholesterol drug NEXLETOL

Esperion stock rises after Japan approves cholesterol drug NEXLETOL  Investing.com

Other

2 w. ago Esperion’s cholesterol drug NEXLETOL receives approval in Japan

Esperion’s cholesterol drug NEXLETOL receives approval in Japan  Investing.com

Other

2 w. ago Alvotech Receives Marketing Approval In Japan For Three New Biosimilars

Alvotech Receives Marketing Approval In Japan For Three New Biosimilars  Nasdaq

Other

2 w. ago Verrica Pharmaceuticals stock soars after Japan approves YCANTH

Verrica Pharmaceuticals stock soars after Japan approves YCANTH  Investing.com

Other

2 w. ago Esperion and Otsuka Receive Approval for NEXLETOL® in Japan for Hypercholesterolemia Treatment

Esperion and Otsuka Receive Approval for NEXLETOL® in Japan for Hypercholesterolemia Treatment  Quiver Quantitative

Other

2 w. ago Verrica Pharmaceuticals Announces $10 Million Milestone Payment Following YCANTH® Approval in Japan for Molluscum Treatment

Verrica Pharmaceuticals Announces $10 Million Milestone Payment Following YCANTH® Approval in Japan for Molluscum Treatment  Quiver Quantitative

Other

2 w. ago Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC  GlobeNewswire

Other